HCA Healthcare, Inc. (NYSE:HCA) is included among the 20 Best Performing Dividend Stocks in 2025. Mizuho Sees Improving Margins Supporting HCA Healthcare into 2026 Mizuho lifted its price target on HCA Healthcare, Inc. (NYSE:HCA) to $520 from $505 on December 18 and kept an Outperform rating as part of its 2026 outlook for managed care and health facilities. The firm sees 2026 as a “pivotal year” for managed care. After roughly three years of pressure from a negative underwriting cycle, margins are expec ...

In this article, we will take a look at some of the best-performing dividend stocks to invest in.2025 has felt like another strong year for stocks. The S&P 500 is up close to 18% so far. If nothing unexpected hits before year-end, this would be the third year in a row with double-digit gains for the broader US market.A lot of that optimism comes back to earnings. Wall Street expects profits to keep growing into 2026, and analysts see S&P 500 earnings rising about 15.5% next year, up from an estimated 13.2% ...

What: HCA Healthcare, Inc. 4Q 2025 Earnings Call When: Tuesday, January 27, 2026 at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx ...

There are some risks to consider before jumping on the bandwagon.Once again, the technology sector drove much of the market's gains this year. The healthcare industry, on the other hand, has been a bit of a laggard.However, there have been notable standouts among medically focused stocks. The list of strong performers includes CRISPR Therapeutics (CRSP +0.44%), a biotech company, and HCA Healthcare (HCA +0.03%), a leading hospital chain. They have outperformed the S&P 500, (^GSPC +0.32%) rising by 44% and 5 ...

Nashville, Tennessee-based HCA Healthcare, Inc. (HCA) is a healthcare services company that owns and operates a broad network of hospitals, surgery centers, freestanding emergency rooms, and urgent care clinics. Valued at a market cap of $107.7 billion, the company is scheduled to announce its fiscal Q4 earnings for 2025 in the near future. Before this event, analysts expect this healthcare giant to report a profit of $7.37 per share, up 18.5% from $6.22 per share in the year-ago quarter. The company has ...

Looking into the current session, HCA Healthcare Inc. (NYSE:HCA) shares are trading at $472.00, after a 0.21% decrease. Over the past month, the stock decreased by 8.48%, but over the past year, it actually spiked by 54.99%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. Comparing HCA Healthcare P/E Against Its PeersThe P/E ratio measures the current share price to the company ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Scores? Dev ...

Group 1 - HCA Healthcare, Inc. operates a network of 190 hospitals and approximately 2,400 ambulatory care sites, with a significant reduction in share count by 44% since the end of 2015 [1] - The stock reached new all-time highs last month but has since pulled back nearly $50 without a specific reason, indicating a potential buying opportunity [1] - L1 Capital has reduced its investment in HCA Healthcare due to strong share price appreciation, although it remains a retained investment, no longer a top 10 holding [2] Group 2 - The market has previously reacted pessimistically to potential regulatory developments affecting HCA, creating opportunities for investment at attractive price levels [2] - Current expectations for operating conditions are more balanced, and the share price has increased significantly, leading to a less favorable risk-adjusted return potential from the current price [2] - There is a belief that certain AI stocks may offer greater upside potential and carry less downside risk compared to HCA [2]

Core Insights - HCA Healthcare UK has successfully implemented MEDITECH Expanse across its 11 acute facilities and numerous outpatient locations, which enhances patient safety and improves workflow efficiencies [1] Company Overview - HCA Healthcare UK is a leading private healthcare provider that focuses on delivering high-quality healthcare services [1] Technology Implementation - The MEDITECH Expanse is an innovative, cloud-based electronic health record (EHR) system that provides clinicians with a unified, multi-disciplinary health record [1] - This system allows for a seamless view of the patient's journey and health status, accessible whenever and wherever the patient receives care [1]

Market Overview - The U.S. stock markets ended the week mostly lower, with the Nasdaq Composite and S&P 500 slipping by 1.49% and 0.28% respectively due to a sharp selloff in tech stocks [1] - The Dow Jones Industrial Average gained 1.51% as investors rotated toward value and traditional sectors [1] Federal Reserve Actions - The Federal Reserve cut its key overnight borrowing rate by a quarter-percentage-point, now in the range of 3.5% to 3.75% [2] - This decision was influenced by signs of gradually cooling inflation, aimed at supporting the labor market and stimulating economic growth [2] - The number of Americans filing new applications for unemployment benefits surged to a 4.5-year high of 236,000, indicating a sharp deterioration in the jobs market [2] Stock Performance and Recommendations - Liquidia Corporation (LQDA) shares gained 43.9% since being upgraded to Zacks Rank 2 (Buy) on October 13, outperforming the S&P 500's 4.4% increase [3][6] - The Bank of N.T. Butterfield & Son Limited (NTB) returned 22.7% since its upgrade to Zacks Rank 1 (Strong Buy) on October 7, compared to the S&P 500's 1.5% increase [4] - Western Digital Corporation (WDC) shares advanced 52.8% since its upgrade to Outperform on October 13, significantly beating the S&P 500's 4.4% increase [7] Portfolio Performance - A hypothetical portfolio of Zacks Rank 1 stocks returned +14.3% in 2025, slightly underperforming the S&P 500 index's +14.9% [11] - The Zacks Model Portfolio has outperformed the S&P index by more than 12 percentage points since 1988, with an annualized average return of +23.9% compared to +11.5% for the S&P 500 index [14] Sector-Specific Stocks - Cencora, Inc. (COR) and Fair Isaac Corporation (FICO) returned 18.7% and 18.6% respectively over the past 12 weeks [15] - Johnson & Johnson (JNJ) returned 19.3% over the past 12 weeks, benefiting from investor demand for quality dividend stocks [19]